Landaas & Company’s Eli Lilly LLY Stock Holding History

Landaas & Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$333K	Sell	278 -122	-31%	-$125K	0.06%	103
2026 Q1	$368K	Hold	400	–	–	0.08%	87
2025 Q4	$430K	Sell	400 -102	-20%	-$97.5K	0.09%	70
2025 Q3	$383K	Hold	502	–	–	0.09%	71
2025 Q2	$391K	Buy	502 +125	+33%	+$97.1K	0.09%	62
2025 Q1	$311K	Hold	377	–	–	0.09%	67
2024 Q4	$291K	Hold	377	–	–	0.08%	63
2024 Q3	$334K	Hold	377	–	–	0.09%	53
2024 Q2	$341K	Hold	377	–	–	0.1%	53
2024 Q1	$293K	Hold	377	–	–	0.1%	59
2023 Q4	$220K	Hold	377	–	–	0.08%	72
2023 Q3	$202K	Buy	+377	New	+$194K	0.09%	72
2018 Q3	–	Sell	-563	Closed	-$48K	–	201
2018 Q2	$48K	Buy	+563	New	+$46.2K	0.04%	155
2018 Q1	–	Sell	-152	Closed	-$13K	–	195
2017 Q4	$13K	Hold	152	–	–	0.01%	235
2017 Q3	$13K	Buy	+152	New	+$12.5K	0.01%	233

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Landaas & Company's LLY Position: Q2 2026 in Review

Landaas & Company reduced its Eli Lilly (LLY) stake by 31% in Q2 2026, selling an estimated $125K and leaving 278 shares worth $333K. The position accounts for 0.06% of the portfolio, ranked #103.

Landaas & Company first reported a position in LLY in Q3 2017 and has held it in 15 quarters since. The position peaked at $430K in Q4 2025. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Landaas & Company held 278 shares of Eli Lilly worth $333K as of Q2 2026.
Landaas & Company sold 122 Eli Lilly shares in Q2 2026, an estimated $125K.
Eli Lilly made up 0.06% of Landaas & Company's portfolio in Q2 2026, its #103 holding.
Landaas & Company first reported a position in Eli Lilly in Q3 2017 and has held it in 15 quarters since.
Landaas & Company's Eli Lilly position peaked at $430K in Q4 2025.
4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Landaas & Company's 13F filing for Q2 2026, filed 21 Jul 2026.